相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
Philippe Moreau et al.
LANCET ONCOLOGY (2021)
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress
Roberto Ronca et al.
CANCER RESEARCH (2020)
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease
Mirella Belleri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress
Arianna Giacomini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
In Situ DNA/Protein Interaction Assay to Visualize Transcriptional Factor Activation
Michela Corsini et al.
METHODS AND PROTOCOLS (2020)
FGF/FGFR Axis-Blockade Leads to Anti-Tumor Activity in Waldenstrom's Macroglobulinemia By Silencing MYD88
Antonio Sacco et al.
BLOOD (2020)
PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma
Tiziana Annese et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression
Sara Matarazzo et al.
CANCERS (2019)
The Autocrine FGF/FGFR System in both Skin and Uveal Melanoma: FGF Trapping as a Possible Therapeutic Approach
Sara Rezzola et al.
CANCERS (2019)
Long pentraxin 3: A novel multifaceted player in cancer
Arianna Giacomini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
New Insights in Anti-Angiogenesis in Multiple Myeloma
Domenico Ribatti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2
Marco Presta et al.
FRONTIERS IN IMMUNOLOGY (2018)
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth
Priscila Fabiana Rodrigues et al.
FRONTIERS IN ONCOLOGY (2018)
Tumor angiogenesis revisited: Regulators and clinical implications
Roberto Ronca et al.
MEDICINAL RESEARCH REVIEWS (2017)
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach
Marco Presta et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors
Riccardo Castelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy
Roberto Ronca et al.
CANCER CELL (2015)
Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients
Antonio Basile et al.
JOURNAL OF PATHOLOGY (2013)
Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature
Cristiana Lavazza et al.
BLOOD (2010)
Antiangiogenic Activity of a Neutralizing Human Single-Chain Antibody Fragment against Fibroblast Growth Factor Receptor 1
Roberto Ronca et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma
D. Ribatti et al.
ONCOGENE (2006)
Angiogenesis in multiple myeloma
Christian Jakob et al.
EUROPEAN JOURNAL OF CANCER (2006)
Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression
S Kumar et al.
BLOOD (2004)
分享论文
